SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-009417
Filing Date
2024-03-26
Accepted
2024-03-26 16:14:46
Documents
115
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nby20231231_10k.htm   iXBRL 10-K 2767431
2 EXHIBIT 10.8+ ex_643824.htm EX-10.8 16324
3 EXHIBIT 21 ex_642660.htm EX-21 1278
4 EXHIBIT 23.1 ex_640528.htm EX-23.1 3468
5 EXHIBIT 31.1 ex_640529.htm EX-31.1 8355
6 EXHIBIT 31.2 ex_640530.htm EX-31.2 8638
7 EXHIBIT 32.1 ex_640531.htm EX-32.1 4427
8 EXHIBIT 32.2 ex_640532.htm EX-32.2 4237
9 EXHIBIT 97 ex_642661.htm EX-97 12690
  Complete submission text file 0001437749-24-009417.txt   13183951

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA nby-20231231.xsd EX-101.SCH 111912
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20231231_cal.xml EX-101.CAL 65330
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20231231_def.xml EX-101.DEF 744667
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20231231_lab.xml EX-101.LAB 575937
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20231231_pre.xml EX-101.PRE 787416
119 EXTRACTED XBRL INSTANCE DOCUMENT nby20231231_10k_htm.xml XML 2594811
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 24783690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)